Vanguard Group Inc Y M Abs Therapeutics, Inc. Transaction History

Vanguard Group Inc

  • $5.97 Trillion
  • Q2 2025

A detailed history of Vanguard Group Inc transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,943,285 shares of YMAB stock, worth $16.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,943,285
Previous 1,946,509 0.17%
Holding current value
$16.7 Million
Previous $8.62 Million 1.64%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
SELL
$3.64 - $5.35 $11,735 - $17,248
-3,224 Reduced 0.17%
1,943,285 $8.76 Million
Q1 2025

May 09, 2025
SELL
$4.43 - $8.17 $237,062 - $437,201
-53,513 Reduced 2.68%
1,946,509 $8.62 Million
Q4 2024

Feb 11, 2025
SELL
$7.76 - $15.69 $274,246 - $554,500
-35,341 Reduced 1.74%
2,000,022 $15.7 Million
Q3 2024

Nov 13, 2024
BUY
$9.95 - $15.39 $776,338 - $1.2 Million
78,024 Added 3.99%
2,035,363 $26.7 Million
Q2 2024

Aug 13, 2024
SELL
$11.6 - $17.25 $1.3 Million - $1.94 Million
-112,178 Reduced 5.42%
1,957,339 $23.6 Million
Q1 2024

May 10, 2024
SELL
$6.57 - $18.69 $1.15 Million - $3.27 Million
-174,721 Reduced 7.79%
2,069,517 $33.7 Million
Q4 2023

Feb 14, 2024
BUY
$4.88 - $7.42 $60,170 - $91,488
12,330 Added 0.55%
2,244,238 $15.3 Million
Q3 2023

Nov 14, 2023
BUY
$4.86 - $7.23 $23,809 - $35,419
4,899 Added 0.22%
2,231,908 $12.2 Million
Q2 2023

Aug 14, 2023
SELL
$5.68 - $10.34 $306,680 - $558,287
-53,993 Reduced 2.37%
2,227,009 $15.1 Million
Q1 2023

May 15, 2023
BUY
$2.83 - $5.11 $64,376 - $116,242
22,748 Added 1.01%
2,281,002 $11.4 Million
Q4 2022

Feb 10, 2023
BUY
$3.0 - $15.17 $1.01 Million - $5.12 Million
337,833 Added 17.59%
2,258,254 $11 Million
Q3 2022

Nov 14, 2022
SELL
$13.96 - $19.67 $132,550 - $186,766
-9,495 Reduced 0.49%
1,920,421 $27.7 Million
Q2 2022

Aug 12, 2022
BUY
$8.22 - $15.13 $1.11 Million - $2.05 Million
135,406 Added 7.55%
1,929,916 $29.2 Million
Q1 2022

May 13, 2022
SELL
$6.55 - $17.42 $147,794 - $393,064
-22,564 Reduced 1.24%
1,794,510 $21.3 Million
Q4 2021

Feb 14, 2022
BUY
$15.51 - $29.31 $203,956 - $385,426
13,150 Added 0.73%
1,817,074 $29.5 Million
Q3 2021

Nov 12, 2021
BUY
$27.47 - $37.31 $4.63 Million - $6.29 Million
168,669 Added 10.31%
1,803,924 $51.5 Million
Q2 2021

Aug 13, 2021
BUY
$25.45 - $37.64 $41.6 Million - $61.6 Million
1,635,255 New
1,635,255 $55.3 Million

Others Institutions Holding YMAB

# of Institutions
97
Shares Held
26M
Call Options Held
24K
Put Options Held
0
View Full List

About Y-mAbs Therapeutics, Inc.

YMAB Quotes by TradingView
  • Ticker YMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,719,500
  • Market Cap $376M
  • Description
  • Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...
More about YMAB
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email